LC-MB12
CAS No. 2828438-38-4
LC-MB12( —— )
Catalog No. M37588 CAS No. 2828438-38-4
LC-MB12 is an orally active, selective and potent PROTAC FGFR2 complex that degrades FGFR2.LC-MB12 has antiproliferative and antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 239 | Get Quote |
|
| 5MG | 328 | Get Quote |
|
| 10MG | 523 | Get Quote |
|
| 25MG | 1012 | Get Quote |
|
| 50MG | 1619 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLC-MB12
-
NoteResearch use only, not for human use.
-
Brief DescriptionLC-MB12 is an orally active, selective and potent PROTAC FGFR2 complex that degrades FGFR2.LC-MB12 has antiproliferative and antitumor activity.
-
DescriptionLC-MB12 is an orally active PROTAC compound targets FGFR2degradation with a DC50 of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity.
-
In VitroCell Viability Assay Cell Line:KATO III, SNU-16, NCI-H716 Concentration:0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:72 h Result:Inhibited cell growth with IC50s value of 29.1 nM (KATO III); 3.7 nM (SNU-16); 3.2 nM (NCI-H716).Cell Cycle Analysis Cell Line:KATO III Concentration:29.1 nM Incubation Time:72 h Result:Induced G0/G1 cycle arrest.ImmunofluorescenceCell Line:KATO IIIConcentration:100 nM Incubation Time:3 h, 6 h Result:Promoted FGFR2 was relocated from the cell membrane to intracellular vesicles after treated for 3 or 6 h. Induced receptor internalization and re-localization to the perinuclear section after 6 h treatment.Western Blot Analysis Cell Line:KATO III, NCI-H1581 Concentration: 0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:6 h Result:Degraded FGFR2 with a DC50 of 11.8 nM and D max of ~80% after 6 h of treatment.Showed time-dependent effect on degradation,with a detectable reduction in FGFR2 levels after 3 h of treatment and ~90% degradation after 12 h.Degraded of FGFR2 in KATO by 77%, and in NCI-H1581 by 43% after 100 nM treatment for 6 h.
-
In VivoAnimal Model:SNU-16 xenografted in BALB/c-nu mice.Dosage:20 mg/kg/day Administration:oral administration (p.o.) 15 days Result:Achieved 63.1% tumor growth inhibition innocuously. Inhibited FGFR phosphorylation and total FGFR2 protein and decreased phosphorylation levels of downstream pPLCγ and ERK1/2.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPROTACs | FGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2828438-38-4
-
Formula Weight899.78
-
Molecular FormulaC43H44Cl2N10O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 130 mg/mL (144.48 mM; Ultrasonic (<60°C)
-
SMILESO=C(NC=1C(Cl)=C(OC)C=C(OC)C1Cl)N(C=2N=CN=C(C2)NC3=CC=C(C=C3)N4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C(=O)C7=C6)C8C(=O)NC(=O)CC8)CC5)CC4)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ma L, et al. Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer. J Med Chem. 2023 Jun 8;66(11):7438-7453.?
molnova catalog
related products
-
METHYL UNDECANOATE
Methyl undecanoate is an internal standard in gas-liquid chromatogram.
-
N-Deshydroxyethyl Da...
N-Deshydroxyethyl Dasatinib (N-Deshydroxyethyl BMS-354825) is a metabolite of Dasatinib, a dasatinib-based molecule that degrades ABL by binding to the IAP ligand via a linker to form SNIPER.
-
Transduction Peptide...
Transduction Peptide 1 (α II)
Cart
sales@molnova.com